Vera Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $3.6M |
| Mar 2020 | — | — | $6.2M |
| Jun 2020 | — | — | $4.1M |
| Sep 2020 | — | — | $1.5M |
| Dec 2020 | $4.3M | $54.6M | $53.7M |
| Mar 2021 | $5.6M | $51.8M | $49.5M |
| Jun 2021 | $5.5M | $97.6M | $91.6M |
| Sep 2021 | $5.7M | $91.2M | $86.2M |
| Dec 2021 | $14.2M | $83.7M | $79.7M |
| Mar 2022 | $30.5M | $165.0M | $111.5M |
| Jun 2022 | $27.3M | $148.8M | $50.4M |
| Sep 2022 | $25.7M | $131.4M | $30.5M |
| Dec 2022 | $54.5M | $131.4M | $43.5M |
| Mar 2023 | $51.9M | $209.6M | $137.4M |
| Jun 2023 | $54.7M | $195.2M | $33.9M |
| Sep 2023 | $51.9M | $175.6M | $27.4M |
| Dec 2023 | $73.9M | $175.5M | $45.7M |
| Mar 2024 | $65.8M | $419.4M | $69.1M |
| Jun 2024 | $69.4M | $397.3M | $25.1M |
| Sep 2024 | $79.5M | $368.6M | $27.3M |
| Dec 2024 | $78.5M | $655.7M | $92.6M |
| Mar 2025 | $75.2M | $610.2M | $55.1M |
| Jun 2025 | $110.3M | $578.5M | $49.1M |
| Sep 2025 | $118.6M | $517.5M | $57.8M |
| Dec 2025 | $130.2M | $734.7M | $354.7M |
| Mar 2026 | $122.0M | $621.7M | $114.4M |
| Jun 2026 | $125.2M | $533.0M | $48.9M |